Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers

被引：13

作者：

Kinoshita, Kazutomo ^{[1
]}

Oikawa, Nobuhiro ^{[1
]}

Tsukuda, Takuo ^{[1
]}

机构：

[1] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa, Japan

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47 | 2012年 / 47卷

关键词：

CELL LUNG-CANCER; EXPERIMENTAL-MODELS; ANTITUMOR-ACTIVITY; RESISTANCE; FUSION; POTENT; IDENTIFICATION; CRIZOTINIB; MUTATIONS; PROTEINS;

D O I：

10.1016/B978-0-12-396492-2.00019-9

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：281 / 293

页数：13

共 44 条

[1] Development and Scale-Up of an Optimized Route to the ALK Inhibitor CEP-28122 [J].

Allwein, Shawn P. ;

Roemmele, Renee C. ;

Haley, James J., Jr. ;

Mowrey, Dale R. ;

Petrillo, Daniel E. ;

Reif, James J. ;

Gingrich, Diane E. ;

Bakale, Roger P. .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (01) :148-155

[2] Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR [J].

Bell, DW ;

Gore, I ;

Okimoto, RA ;

Godin-Heymann, N ;

Sordella, R ;

Mulloy, R ;

Sharma, SV ;

Brannigan, BW ;

Mohapatra, G ;

Settleman, J ;

Haber, DA .

NATURE GENETICS, 2005, 37 (12) :1315-1316

[3] Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors [J].

Bossi, Roberto T. ;

Saccardo, M. Beatrice ;

Ardini, Elena ;

Menichincheri, Maria ;

Rusconi, Luisa ;

Magnaghi, Paola ;

Orsini, Paolo ;

Avanzi, Nilla ;

Borgia, Andrea Lombardi ;

Nesi, Marcella ;

Bandiera, Tiziano ;

Fogliatto, Gianpaolo ;

Bertrand, Jay A. .

BIOCHEMISTRY, 2010, 49 (32) :6813-6825

[4] Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles [J].

Breslin, Henry J. ;

Lane, Brandon M. ;

Ott, Gregory R. ;

Ghose, Arup K. ;

Angeles, Thelma S. ;

Albom, Mark S. ;

Cheng, Mangeng ;

Wan, Weihua ;

Haltiwanger, R. Curtis ;

Wells-Knecht, Kevin J. ;

Dorsey, Bruce D. .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) :449-464

[5] Rapid Development of Piperidine Carboxamides as Potent and Selective Anaplastic Lymphoma Kinase Inhibitors [J].

Bryan, Marian C. ;

Whittington, Douglas A. ;

Doherty, Elizabeth M. ;

Falsey, James R. ;

Cheng, Alan C. ;

Emkey, Renee ;

Brake, Rachael L. ;

Lewis, Richard T. .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (04) :1698-1705

[6] Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC). [J].

Camidge, D. R. ;

Bang, Y. ;

Kwak, E. L. ;

Shaw, A. T. ;

Iafrate, A. J. ;

Maki, R. G. ;

Solomon, B. J. ;

Ou, S. I. ;

Salgia, R. ;

Wilner, K. D. ;

Costa, D. B. ;

Shapiro, G. ;

LoRusso, P. ;

Stephenson, P. ;

Tang, Y. ;

Ruffner, K. ;

Clark, J. W. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[7] Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug [J].

Capdeville, R ;

Buchdunger, E ;

Zimmermann, J ;

Matter, A .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :493-502

[8] Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity [J].

Chamberlain, Stanley D. ;

Redman, Aniko M. ;

Wilson, Joseph W. ;

Deanda, Felix ;

Shotwell, J. Brad ;

Gerding, Roseanne ;

Lei, Huangshu ;

Yang, Bin ;

Stevens, Kirk L. ;

Hassell, Anne M. ;

Shewchuk, Lisa M. ;

Leesnitzer, M. Anthony ;

Smith, Jeffery L. ;

Sabbatini, Peter ;

Atkins, Charity ;

Groy, Arthur ;

Rowand, Jason L. ;

Kumar, Rakesh ;

Mook, Robert A., Jr. ;

Moorthy, Ganesh ;

Patnaik, Samarjit .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) :360-364

[9] CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers [J].

Cheng, Mangeng ;

Quail, Matthew R. ;

Gingrich, Diane E. ;

Ott, Gregory R. ;

Lu, Lihui ;

Wan, Weihua ;

Albom, Mark S. ;

Angeles, Thelma S. ;

Aimone, Lisa D. ;

Cristofani, Flavio ;

Machiorlatti, Rodolfo ;

Abele, Cristina ;

Ator, Mark A. ;

Dorsey, Bruce D. ;

Inghirami, Giorgio ;

Ruggeri, Bruce A. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :670-679

[10] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors [J].

Choi, Young Lim ;

Soda, Manabu ;

Yamashita, Yoshihiro ;

Ueno, Toshihide ;

Takashima, Junpei ;

Nakajima, Takahiro ;

Yatabe, Yasushi ;

Takeuchi, Kengo ;

Hamada, Toru ;

Haruta, Hidenori ;

Ishikawa, Yuichi ;

Kimura, Hideki ;

Mitsudomi, Tetsuya ;

Tanio, Yoshiro ;

Mano, Hiroyuki .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1734-1739

← 1 2 3 4 5 →